Asua V, Niaré K, Garg S, Legac J, Tukwasibwe S, Katairo T, Bohissou FE, Crudale RM, Simkin A, Mulondo J, Nsobya SL, Ssewanyana I, Dorsey G, Bailey JA, Kamya MR, Yeka A, Rosenthal PJ, Borrmann S, Conrad MD. Multiple local PfDHFR I164L haplotype expansions drive Plasmodium falciparum antifolate resistance in Uganda. Nat Commun. 2026 Sep 04; 17(1).

Moreira-Nascimento SL, Nascimento MFA, Fernandes GM, Afonso SL, Gunderman VHG, Rodrigues BA, Lopes SCP, Fabbri C, Lacerda MVG, Almeida GG, Longley RJ, Mueller I, Antonelli LRDV, Ntumngia FB, Adams JH, Teixeira-Carvalho A, Carvalho LH, Kano FS. Cytokine signatures associated with persistent antibody responses to multiple Plasmodium vivax blood-stage antigens. Front Immunol. 2026; 17:1899417.

Niaré K, Tafesse B, Treat M, Sadler JM, Okitwi M, Orena S, Asua V, Kreutzfeld O, Legac J, Marglous J, Nsobya SL, Yeka A, Richard D, Ferdig MT, Mukherjee A, Rosenthal PJ, Juliano JJ, Bailey JA, Conrad MD. Emergence and spread of Plasmodium falciparum PX1 polymorphisms associated with decreased susceptibility to antimalarials in Uganda. Nat Med. 2026 Sep; 32(9):3192-3202.

Geleta D, Brhane BG, Abera A, Belachew M, Sime H, Gebreegziaxher A, Getu M, Ali A, Tesfay N, Habtetsion M, Kokobe B, Kebede M, Worku Z, Tasew G, Tadesse G, Tollera G, Fola AA, Bailey JA, Juliano JJ, Parr JB, Abte M, Assefa A. Recurrent parasitemias with artemisinin partial resistance mutations during the 2024 Ethiopia malaria resurgence: a case series. Malar J. 2026 Jul 31; 25(1).

Connelly SV, Cunningham C, Petrow I, Rustamzade N, Zuromski J, Sipolski DM, Nixon CP, Kurtis JD, Juliano JJ, Bailey JA, Oduor CI. Single-cell transcriptional changes of artemisinin-sensitive K13C580 and artemisinin-resistant K13580YPlasmodium falciparum upon dihydroartemisinin exposure. Front Cell Infect Microbiol. 2026; 16:1816105.

Zeleke AJ, Fola AA, Tollefson GA, Niaré K, Leonetti A, Taropawala O, Marglous J, Crudale R, Brhane BG, Assefa A, Kiyuka P, Parr JB, Hailu A, Tegegne MA, Bailey JA. High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia. PLoS Pathog. 2025 12; 21(12):e1013771.

Cummings BE, Stucke EM, Coulibaly D, Lawton JG, Sobota RS, Kone AK, Kane B, Guindo B, Tangara B, Sissoko M, Maiga F, Traore K, Diawara A, Traore A, Thera A, Dara A, Niangaly A, Daou M, Diarra I, Tolo Y, Sebastian S, Jain A, Nakajima R, Jasinskas A, Silzel EK, Shrestha B, Ouattara A, Munro JB, Laurens MB, Lyke KE, Tebben K, Bogale H, Plowe CV, Sissoko MS, Kouriba B, Takala-Harrison S, Felgner PL, Silva JC, Doumbo OK, Thera MA, Travassos MA. Plasmodium falciparum gene expression signatures and antibody profiling implicate the fikk, phist, and surf multigene families in severe malaria syndromes. J Infect. 2025 Dec; 91(6):106655.

Dos Santos NSA, de Almeida-Júnior CR, Ricci MF, Sanches RCO, Fernandes RS, Burle-Caldas GA, de Castro JT, Reis-Cunha JL, Bartholomeu DC, Meira ACM, Nascimento TG, Oliveira NFM, Gazzinelli RT, Machado FS, Teixeira SMR. RNA and protein immunization with Trypanosoma cruzi trans-sialidase containing SAPA repeats protects mice against infection and promotes a balanced inflammatory response. Front Cell Infect Microbiol. 2025; 15:1681807.

Martin AC, Sadler JM, Simkin A, Musonda M, Katowa B, Matoba J, Schue J, Simulundu E, Bailey JA, Moss WJ, Juliano JJ, Fola AA. Emergence and Rising Prevalence of Artemisinin Partial Resistance Marker Kelch13 P441L in a Low Malaria Transmission Setting in Southern Zambia. J Infect Dis. 2025 Oct 15; 232(4):918-922.

Watson OJ, Tran TN, Zupko RJ, Symons T, Thomson R, Visser T, Rumisha S, Dzianach PA, Hathaway N, Kim I, Juliano JJ, Bailey JA, Slater H, Okell L, Gething P, Ghani A, Boni MF, Parr JB, Cunningham J. Global risk of selection and spread of Plasmodium falciparum histidine-rich protein 2 and 3 gene deletions. Nat Med. 2025 Oct; 31(10):3372-3379.